KR20060125081A - Manufacturing method of anticancer egg and anticancer egg - Google Patents
Manufacturing method of anticancer egg and anticancer egg Download PDFInfo
- Publication number
- KR20060125081A KR20060125081A KR1020050046891A KR20050046891A KR20060125081A KR 20060125081 A KR20060125081 A KR 20060125081A KR 1020050046891 A KR1020050046891 A KR 1020050046891A KR 20050046891 A KR20050046891 A KR 20050046891A KR 20060125081 A KR20060125081 A KR 20060125081A
- Authority
- KR
- South Korea
- Prior art keywords
- powder
- mother
- egg
- juniper
- weight
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K40/00—Shaping or working-up of animal feeding-stuffs
- A23K40/10—Shaping or working-up of animal feeding-stuffs by agglomeration; by granulation, e.g. making powders
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L15/00—Egg products; Preparation or treatment thereof
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Health & Medical Sciences (AREA)
- Botany (AREA)
- Animal Husbandry (AREA)
- Physiology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Nutrition Science (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
도 1은 본 발명에 따른 BLC 계란에 의한 세포고사를 나타내는 사진1 is a photograph showing the cell death by BLC eggs according to the present invention
도 2는 본 발명에 따른 BLC 계란에 의한 DNA ladder를 나타내는 도면Figure 2 is a diagram showing the DNA ladder by the BLC egg according to the present invention
도 3은 본 발명에 따른 BLC 계란에 의한 종양의 크기 변화를 나타내는 그래프Figure 3 is a graph showing the change in tumor size by BLC eggs according to the present invention
도 4는 본 발명에 따른 BLC 계란에 의한 종양의 크기 변화를 나타내는 사진Figure 4 is a photograph showing the change in tumor size caused by BLC eggs according to the present invention
도 5는 본 발명에 따른 BLC계란에 의한 유방암세포의 성장 억제 효과를 나타내는 그래프5 is a graph showing the growth inhibitory effect of breast cancer cells by BLC eggs according to the present invention
본 발명은 항암기능성계란 제조방법과 계란에 관한 것으로, 보다 상세하게는 모자반과 주엽나무를 혼합하여 액을 추출하거나 분말을 제조하여, 이들을 닭에게 먹임으로써 계란을 얻을 수 있도록 하는 것이다.The present invention relates to a method for producing anticancer functional eggs and eggs, and more specifically, to mix the mother and a juniper tree to extract the liquid or to prepare a powder, so that they can be obtained by feeding the chicken eggs.
모자반(Sargassum fulvellum)은 한국, 일본등의 바다에 널리 분포하고 있는 갈조류로써, 높이 1∼3m이고 아래쪽이 원반 모양으로 되어 있다. 가지는 세모진 기둥모양 또는 삼각형이며 비틀려 있다. 잎은 아래로 휘어 주걱모양 또는 타원형이며 잎의 중앙까지 약한 중륵(中肋)이 있다. 상부의 잎은 바늘모양이며 톱니가 있고 중륵은 없으며 암황갈색이다. 기포는 여러 개 있고 위치에 따라 모양이 다르며, 가지의 기부(基部)에 있는 것은 상부에 있는 것보다 크다. 생식기탁(生殖器托)은 긴 원주상(圓柱狀)이며, 짧은자루가 있고 총상(總狀)으로 배열한다. 저조선(低潮線) 부근의 암석에 나며 식용 및 사료로 이용된다. 한국·일본 등지에 분포한다. Sargassum fulvellum is a brown algae widely distributed in the seas of Korea and Japan, and has a height of 1 to 3m and a disk shape at the bottom. The branch is triangular or triangular and twisted. The leaf is bent downward, spatula or oval, with a weak middle to the center of the leaf. Upper leaf is needle-shaped, serrate, without middle, dark yellowish brown. There are several bubbles and the shape varies according to the position, and the base of the branch is larger than the upper one. Reproductive deposits are long, columnar, with short stalks, arranged in gunshots. It grows in rocks near low ships and is used for food and feed. It is distributed in Korea and Japan.
그리고, 선행기술(출원번호10-2003-0002053)에서는 자궁암 세포실험 결과 모자반 추출액 1,600㎍/㎖농도에서 자궁암세포 생존율은 0.6%로서 99.4%의 제암력이 확인 되었다In the prior art (Application No. 10-2003-0002053), as a result of uterine cancer cell experiment, uterine cancer cell survival rate was 0.6% and 99.4% anticancer activity was observed at 1,600 µg / ml concentration of Maban extract.
한편, 주엽나무(Gleditschia japonica var koraensis Nakai)는 소엽이 전연하며 자침이 소형이고 협과는 반전하고 있으며 우리나라 전역과 일본, 중국등지에 분포한다. 가시가 없는 것을 민주엽나무(Gleditsia japonica for inarmata), 열매가 꼬이지 않고 약간 굽는 것을 아자비과즐나무(Gleditsia japonica var stenocarpa), 가시가 굵으며 그 단면이 둥글고 열매가 꼬이지 않는 것을 중국 주엽나무 또는 조각자나무(Gleditsia sinensis), 주엽나무와 비슷하지만 작은 잎은 길이 15-35mm로서 보다 작고 가시가 조각자와 비슷하게 단면이 둥글며 꼬투리는 아자비과즐처럼 꼬이지 않는 것을 일본주엽나무(Gleditsia japonica)라고 하며 주엽나무목(Gleditsia Linn)에 속한다.On the other hand, the juvenile tree (Gleditschia japonica var koraensis Nakai) has the leaflets inverted, the needles are small, and the stalks are inverted. Gleditsia japonica for inarmata, without thorns, a little unroasted, with a little kerchief (Gleditsia japonica var stenocarpa), with thick thorns, rounded and untwined (Gleditsia sinensis), similar to the juniper tree, but small leaves 15-35mm long, smaller, spiny, rounded in cross section similar to sculptor, and not twisted like pods of azabis. Gleditsia japonica is called juniper tree (Gleditsia Linn). Belongs to).
그러나, 뛰어난 함암억제 기능이 입증되고 있음에도 불구하고, 국내에 흔히 분포하는 모자반과 주엽나무를 이용할 방법이 지금까지 제안되지 않았다.However, despite the fact that excellent anti-cancer function has been proved, no method has been proposed so far using the mother-child and juniper trees commonly distributed in Korea.
본 발명의 목적은 모자반과 주엽나무를 이용하여 항암특성이 우수한 기능성계란을 얻는 데 있다.An object of the present invention is to obtain a functional egg excellent in anticancer properties using a mother and a juniper tree.
상기한 목적을 달성하기 위한 본 발명의 특징은 모자반과 주엽나무를 혼합하여 액을 추출하거나 분말을 제조하여, 닭에게 먹여 항암기능성계란을 얻는 데 있다.A feature of the present invention for achieving the above object is to obtain a cancer-fighting egg by feeding the chicken by extracting the liquid or preparing a powder by mixing the mother and a juniper tree.
상기한 모자반과 주엽나무를 혼합하는 방법은 모자반과 주엽나무를 세절한 후 부위별로(주엽나무의 경우 잎, 열매, 가시부위를 말하며 이하 같다) 골고루 평량하여 모자반 총중량에 대하여 주엽나무를 5-15중량%로 혼합한 후, 증류수로 열수추출한다. 또다른 방법은, 세절한 후 부위별로 골고루 평량하고 모자반은 건조하여 수분 t량이 15-25%가 되게 한 다음 50-150메쉬(mesh)로 각각 마쇄하여 분말화한 후, 모자반의 총중량에 대하여 주엽나무를 5-15중량%로 혼합한다.The method of mixing the banban and jujube tree is to cut the banban and jujube tree evenly after each section (in the case of jujube, leaves, berries, and thorns are the same). After mixing by weight%, hot water is extracted with distilled water. Another method is to equalize evenly by section after cutting, and to dry the hatban to make 15-25% of moisture, and then pulverized by 50-150 mesh (mesh), and then to the total weight of the hatban. Mix 5-15% by weight of wood.
상기한 바와 같은 특징을 갖는 본 발명의 실시예를 하기에서 보다 상세하게 살펴본다.An embodiment of the present invention having the features as described above will be described in more detail below.
가. BLC추출액 제조end. BLC Extract Preparation
모자반(Sargassum fulvellum)과 주엽나무(Gleditschia japonica var koraensis Nakai)를 채집, 수집, 선정하고 기원을 감정한후 동정(Identification)하고 세절한후 부위별로 골고루 평량하여 모자반 5000g과 주엽나무 500g을 취한 다음, 둥근 플라스크 2중추출장치에 넣고 증류수 18ℓ를 투여하여 160℃에서 4시간동안 Boiling하여 멸균 추출하고 여과하여 약 9ℓ의 추출액(이하 BLC추출액이라 한다)을 제조한다.After collecting, collecting, selecting and evaluating the origin of Sargassum fulvellum and Gleditschia japonica var koraensis Nakai, identifying the origin, cutting it down, and then evenly weighing the banban 5000g and juniper 500g. In a round flask double extracting device, 18 L of distilled water was administered, boiled at 160 ° C. for 4 hours, sterilized and filtered to prepare an extract of about 9 L (hereinafter referred to as BLC extract).
나. BLC분말 제조I. BLC Powder Manufacturing
모자반과 주엽나무를 채집, 수집, 선정하고 기원을 감정한후 동정하고 세절한후 부위별로 골고루 평량하고 모자반은 수분함량이 15-25%로 되게 건조한 다음 모자반 5000g과 주엽나무 500g을 취하여 100mesh로 마쇄하고 혼합하여 분말(이하 BLC분말이라 한다)을 제조한다.After collecting, collecting, selecting, and evaluating the banban and juniper trees, identifying them, cutting them, and then evenly weighing them by area. The banban is dried to 15-25% of moisture, and then crushed into 100mesh by taking 5000g of banban and 500g of jujube. And mixed to prepare a powder (hereinafter referred to as BLC powder).
다. BLC 계란 제조All. BLC Egg Manufacturer
상기 BLC추출액을 증류수에 BLC추출액 1: 증류수 50-60(바람직하게는 55)의 비율로 희석하여 산란계에게 음수용으로 30일간 먹여서 사육한다. 산란계 산란 주령 2의 적정 계사온도( 21℃)에서의 1일 음수량은 약 190㎖이다.The BLC extract is diluted in distilled water at a ratio of BLC extract 1: 50-60 (preferably 55) of distilled water and fed to the laying hens for 30 days for drinking. The daily amount of drinking water at an appropriate cage temperature (21 ° C.) of laying hens is 2 weeks.
혹은, 산란계용 일반사료에 상기 제조된 분말을 사료에 대하여 각각 모자반 10중량%, 주엽나무 1중량%를 첨가하여 사료를 제조하고, 모자반과 주엽나무의 분말을 함유한 사료를 산란계에게 30일간 공급하여 사육한다. 산란계 1.8㎏의 1일 먹는 사료량은 약 120g이다.Alternatively, the prepared powder is added to the general feed for laying hens by adding 10% by weight of mabanban and 1% by weight of juniper to the feed, respectively, and feeding the feed containing the powder of maban and jujube to the laying hens for 30 days. Breed by The daily feed of 1.8 kg of laying hens is about 120 g.
상기한 바와 같은 산란계로부터 얻은 계란(이하 BLC 계란이라 한다)의 특징 을 살펴보면, 보통계란은 껍질을 벗긴 난자의 색이 황색이며 약간의 비린내가 나는데 비하여, 상기 항암 기능성 계란은 연한 등적색이며 비린내가 나지않고 다소 구수한 냄새와 맛이 난다.Looking at the characteristics of the eggs obtained from the laying hens (hereinafter referred to as BLC eggs), the egg is eggshell color of the egg is yellow and slightly fishy, whereas the anti-cancer functional egg is pale reddish and fishy It smells and tastes rather delicious.
상기한 바와 같은 구성을 갖는 항암기능성 계란의 항암특성을 하기에서 살펴본다.The anticancer properties of the anticancer functional egg having the configuration as described above will be described below.
우선, BLC추출액을 희석없이 그대로 30일간 음수용으로 먹은 산란계가 생산한 BLC계란의 농축 분말은 400㎍/㎖농도의 세포실험에서 유방암 세포의 수를 30% 감소시켰으며, BLC계란을 -40∼-50℃의 온도와 기압 1 x 10-1mb에서 30분간 진공,동결,건조하여 만든 BLC계란농축분말 1000㎎/㎏/day동물실험에서 유방암 종양의 무게를 71.4% 감소시켰다(kg은 동물의 체중을 나타내며 이하 같다)First, the concentrated powder of BLC eggs produced by laying hens, which were fed BLC extracts for 30 days without dilution, reduced the number of breast cancer cells by 30% in cell experiments of 400 µg / ml and the BLC eggs were -40 to The weight of breast cancer tumors was reduced by 71.4% in BLC-based egg powder 1000 mg / kg / day animal experiments made by vacuum, freezing and drying at -50 ° C and air pressure of 1 x 10 -1 mb for 30 minutes. Represents weight and is equal to or less)
그리고, 상기한 BLC계란(BLC/HEN egg)이 사람의 유방암 세포에서 어떠한 기전으로 성장을 억제하고 세포의 proliferation이 감소하였는지를 알아보기 위하여, BLC/HEN egg를 100㎍/㎖의 농도에서 48시간동안 처치한 후, Hoechst 33258 staining을 실시하여 세포의 morphology를 관찰할 결과, 도 1에 나타내는 바와 같이 대조군(Untreated)과 비교하여 BLC/HEN egg를 처치한 세포에서 유방암 세포의 proliferation이 줄어들었고, 세포고사가 유도된 세포에서는 세포고사의 특징적인 현상인 핵산 분절 및 응축이 유도되는 것을 관찰할 수 있었다.In addition, in order to investigate the mechanism by which the BLC egg (BLC / HEN egg) inhibits growth in human breast cancer cells and reduces the proliferation of the cells, the BLC / HEN egg is used at a concentration of 100 µg / ml for 48 hours. After the treatment, Hoechst 33258 staining was performed to observe the morphology of the cells. As shown in FIG. 1, the proliferation of breast cancer cells was decreased in the cells treated with BLC / HEN egg as compared to the control group (Untreated). Induced nucleic acid fragmentation and condensation were observed in cells induced by apoptosis.
또한, 사람의 유방암 세포가 BLC/HEN egg에 노출되었을 때 세포고사를 유도 하는지 확인하기 이하여 DNA laddering을 수행한 결과 BLC/HEN egg를 100㎍/㎖의 농도로 48시간 동안 MCF-7세포에 처치하였을 때, 도 2에 나타내는 바와 같이 DNA fragmentation을 특징적으로 관찰할 수 있는 ladder를 형성하였다.In addition, to confirm whether human breast cancer cells induce apoptosis when exposed to BLC / HEN egg, DNA laddering was performed. As a result, BLC / HEN egg was injected into MCF-7 cells at a concentration of 100 µg / ml for 48 hours. At the time of treatment, as shown in Fig. 2, a ladder was formed in which DNA fragmentation can be observed characteristically.
이러한 BLC 계란에 의한 유방암세포의 세포고사 과정은, 세포사멸을 촉진하는 Bax단백질의 발현을 증가시키고 동시에 세포사멸을 억제하는 Bcl-2단백질의 발현을 감소시킴으로써 DNA repair에 관련된 death substrate인 PARP의 cleavage를 통해 세포사멸 기작이 일어나는 것으로 판단되었다In the process of apoptosis of breast cancer cells by BLC eggs, cleavage of PARP, a death substrate related to DNA repair by increasing the expression of Bax protein that promotes cell death and reducing the expression of Bcl-2 protein that inhibits cell death. The apoptosis mechanism was thought to occur through
그리고, 상기한 BLC 계란은 인체의 대표적 암억제 유전자인 p53단백질의 발현을 증가시킴으로서 사람의 유방암세포 증식을 억제시키는 것으로 나타났다 In addition, the BLC egg suppresses the proliferation of human breast cancer cells by increasing the expression of p53 protein, a representative cancer suppressor gene in the human body.
또한, BLC 계란 농축 분말을 EtOH를 사용하여 stock을 만든후, 농도별로 배지에 희석하여 사람의 유방암세포에서 72시간 동안 성장억제 효과를 확인한 결과 도 5에서 나타낸 바와 같이 유방암세포의 증식이 농도 의존적으로 감소되는 경향이 관찰되었으며, 특히 BLC 계란 농축 분말 400㎍/㎖의 농도에서 사람의 유방암 세포의 억제효과가 이를 처치하지 않은 대조군 대비 30%로 나타났다.In addition, BLC egg concentrate powder was made of stock using EtOH, and then diluted in medium for each concentration to confirm growth inhibition effect in human breast cancer cells for 72 hours. As shown in FIG. 5, the proliferation of breast cancer cells was concentration-dependent. A tendency to decrease was observed, especially at a concentration of 400 µg / ml BLC egg concentrate powder, the inhibitory effect of human breast cancer cells was 30% compared to the control group not treated.
그리고, 상기한 BLC 계란 농축 분말을 4,000ppm의 용량으로 AIN-76A Diet와 배합한 사료를 누드 마우스에 자유섭취 시키며, 음수는 고압증기 멸균된 상수도를 자유섭취 시키되, MCF-7세포를 마우스에 이식하기 전 28일동안 BLC 계란 농축 분말이 배합된 사료를 섭취시킨후 29일째 되는날 사람의 유방암세포인 MCF-7세포를 이식하였다. 그리고 29일부터 56일까지인, 세포이식후 28일 동안 동량의 BLC 계란 농 축 분말이 배합된 사료를 섭취시킨후 마우스를 부검하여 종양의 무게를 측정한 결과 BLC 계란 분말을 처치하지 않은 대조군 대비 71.4% 감소하였다In addition, the BLC egg-concentrated powder was ingested with AIN-76A Diet at a dose of 4,000 ppm freely in nude mice, and the negative water was freely ingested with autoclave water, but MCF-7 cells were transplanted into mice. Human breast cancer cells, MCF-7 cells, were transplanted on the 29th day after the diet containing the BLC egg concentrate powder was fed for 28 days. After ingestion of the feed containing the same amount of BLC egg concentrate powder for 28 days after cell transplantation, which ranged from 29 to 56 days, the tumors were weighed by autopsy and compared with the control group without the BLC egg powder. % Decreased
상기한 BLC 계란(BLC/HEN egg)에 의한 종양의 크기변화를 도 3과 도 4에 나타내었으며, 대조구에 비하여 종양이 매우 감소되는 것을 확인할 수 있다.The size change of the tumor by the BLC egg (BLC / HEN egg) is shown in Figures 3 and 4, it can be seen that the tumor is significantly reduced compared to the control.
본 시험은 서울대학교 수의학과에 용역의뢰하여 실시하였으며 BLC추출액과 동시에 실시하였다.This test was conducted by the veterinary department of Seoul National University and simultaneously with the BLC extract.
또한, 상기한 모자반에는 Lg protein, Policonoid, Viotinogen, Asphaltic Acid, Alaninogen, Nitrominoid, Linanogen, Geroniolein, Rivoflavinoid등의 성분이 포함되어 있다.In addition, the mother board includes components such as Lg protein, Policonoid, Viotinogen, Asphaltic Acid, Alaninogen, Nitrominoid, Linanogen, Geroniolein, and Rivoflavinoid.
이중에서 Lg protein은 전립선 암세포 성장을 억제하고(Koch S;2000), Policonoid은 성인 여자 암세포 전이 증식 억제력 있음이 검증됨(Adamek H E;1999)과 함께 인체 혈구 생성력, 효소 발육력, 뇌세포 활성력, 자궁암 세포 HeLa Cell 주효소 생성 저해력이 있으며, 인체 신경관 발암 저지력 있음이 검증되었다.(Cus kelly G; 1999)Among them, Lg protein inhibits prostate cancer cell growth (Koch S; 2000), and Policonoid has been proven to inhibit adult female cancer cell metastasis proliferation (Adamek HE; 1999). It has been demonstrated that uterine cancer cells have HeLa Cell main enzyme production inhibitory activity and human neural tube carcinogenesis inhibitory activity (Cus kelly G; 1999).
그리고, Biotinogen은 인체 췌장암 치료에 효능이 있음이 검증되었고(Murat A;2000), Avidin-biotin-peroxidase는 인체 식도암 억제 기능이 있음이 검증되었다(Raida M; 1999).Biotinogen has been shown to be effective in the treatment of human pancreatic cancer (Murat A; 2000), and Avidin-biotin-peroxidase has been shown to inhibit human esophageal cancer (Raida M; 1999).
Asphaltic Acid는 인체 항종양 적혈구 성장기능 있음이 검증되었고(Gigoux V, Univ. Rang. France;1999), Alaninogen는 뇌신경 암세포 증식 억제력 있음이 검증되었으며(Wu S N;2000), Nitrominoid는 임파 육종 백혈병 Gall Cancer Cell 증식 억제력이 있으며(J Tokida;1959), 암종양세포 line의 치료 효능이 있음이 검증되었다(White I N;1989).Asphaltic acid has been demonstrated to have human antitumor erythrocyte growth function (Gigoux V, Univ. Rang. France; 1999), Alaninogen has been shown to inhibit neuronal cancer cell proliferation (Wu SN; 2000), and Nitrominoid is lymphocytic leukemia Gall Cancer Cell proliferation inhibitory activity (J Tokida; 1959) and the efficacy of treatment of cancer tumor cell line has been verified (White IN; 1989).
Linanogen는 인체 신경계 세포막의 암세포 성장 억제 효능이 있음이 검증되었고(Elisabetsky E;1999), Geroniolein는 인체 폐암 및 피부암 세포 성장 억제력 있음이 검증되었으며(Yu S G, Wisconsin Univ.;1995), Rivoflavinoid는 인체 구강암 및 인두암 치료 효능이 있음이 검증되었다(Negri E; 2000).Linanogen has been shown to inhibit cancer cell growth of human nervous system membranes (Elisabetsky E; 1999), Geroniolein has been shown to inhibit human lung and skin cancer cell growth (Yu SG, Wisconsin Univ .; 1995), and Rivoflavinoid is human oral cancer And pharyngeal cancer therapeutic efficacy (Negri E; 2000).
그리고, 상기한 주엽나무 에는 글레디트시아-사포닌, 세릴 알코올, 노나코산, 스티그마스테롤, 시토스테롤, 피세틴, 글레디트신, 푸스틴, 트리아칸틴의 9가지 성분이 있다.In addition, the above-mentioned jujube tree has nine components, such as glycidia-saponin, seryl alcohol, nonacoic acid, stigmasterol, cytosterol, phycetin, glycidsin, fustin, and triacanthin.
이 중, Gleditschia-saponine 은 항암, 항균, 배농, 소염, 거담의 효능이 있고, G. sapogenin은 G. saponine 의 분해에 의해 생기는 비당질로 트리텔페노이드와 스테로이드, 성분으로 대별되며, Gleditschia-saponine 와 동류의 효능을 갖는다.Among them, Gleditschia-saponine has the efficacy of anti-cancer, antibacterial, drainage, anti-inflammatory and expectorant. G. sapogenin is a non-saccharide that is produced by the decomposition of G. saponine, and is divided into tritelfenoids, steroids, and ingredients. Gleditschia-saponine Has the same potency as
Gledigenin 및 Gledinin는 G. sapogenin의 효능을 갖는다.Gledigenin and Gledinin have the efficacy of G. sapogenin.
올레놀산 (카리요필린)은 트리텔페노이드와 동류의 효능을 갖고, 에치노시스트산은 정상세포의 호흡증진 효능을 가지며, 프로사포제닌은 사포제닌의 전구 당 배당체로 G. sapogenin의 효능을 갖는다.Olenolic acid (caryophylline) has the same potency as tritelfenoids, echinocystic acid has the respiratory boosting effect of normal cells, and prosapogenin has the effect of G. sapogenin as the prosaccharide glycoside of sapogenin.
펜토오스는 알도당과 케토당으로 되어 있으며, 아라지노오스는 알도펜토오스 의 일종이다. 에치노시스트산의 조기능을 갖는다.Pentose is composed of aldose and keto sugar, and arazinoose is a kind of aldopentose. Has the crude function of echinocystic acid.
한편, 상기한 본 발명의 실시예에서 항암실험은 유방암에 대해서만 하였으나, 상기한 바와 같이 모자반과 주엽나무의 성분에 포함된 각종 성분들이 유방암외에 각종 암에 대하여 항암 효능을 보이고 있으므로, 본 발명은 유방암을 포함한 각종 암에 적용이 가능하다.On the other hand, in the above-described embodiment of the present invention, the anticancer experiment was performed only for breast cancer, but as described above, various components included in the components of the mother and abacus showed anticancer efficacy against various cancers in addition to breast cancer. Applicable to various cancers, including.
상기한 바와 같은 본 발명에 의하면 우리나라에서 쉽게 얻을 수 있는 모자반과 주엽나무를 이용하여 추출액 및 분말을 만들고 이를 이용하여 항암 기능성을 갖는 계란을 얻을 수 있게 된다.According to the present invention as described above it is possible to obtain an egg with anticancer function by making an extract and powder using a mother and a juniper tree easily obtained in Korea.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020050046891A KR100670615B1 (en) | 2005-06-01 | 2005-06-01 | Manufacturing method of anticancer egg and anticancer egg |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020050046891A KR100670615B1 (en) | 2005-06-01 | 2005-06-01 | Manufacturing method of anticancer egg and anticancer egg |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20060125081A true KR20060125081A (en) | 2006-12-06 |
KR100670615B1 KR100670615B1 (en) | 2007-01-17 |
Family
ID=37729524
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020050046891A KR100670615B1 (en) | 2005-06-01 | 2005-06-01 | Manufacturing method of anticancer egg and anticancer egg |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100670615B1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101239175B1 (en) * | 2009-08-28 | 2013-03-06 | 박헌경 | Method for manufacturing fodder with blc powder |
KR101872159B1 (en) * | 2017-06-29 | 2018-07-31 | 서정익 | Composition for the production of egg containing combated cancer and its Manufacturing method |
KR20190119312A (en) * | 2018-04-12 | 2019-10-22 | 재단법인 경기도경제과학진흥원 | Insecticidal and Miticidal Composition of Red Poultry Mite Using an Extract of Gleditsiae Fructus |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR0160107B1 (en) * | 1995-06-14 | 1998-12-01 | 최영태 | Antibacterial agent containing the extract of gleditschia officinalis |
KR20010104836A (en) * | 2000-05-16 | 2001-11-28 | 이원익 | The manufacturing method for feed of livestock which is utilized by seaware |
KR100477320B1 (en) * | 2002-10-31 | 2005-03-21 | 김거리 | Feed containing gulfweed for layer and egg produced using thereof |
KR20040092302A (en) * | 2003-04-26 | 2004-11-03 | 윤광식 | Health Caring Food with Anticancer Activity Comprising the Extract of Sargassum fulvellum |
KR100604142B1 (en) * | 2004-06-02 | 2006-07-25 | 주식회사 도들샘 | Kimchi with anticancer activity containing the extract of sargassum fulvellum, and a process for preparation thereof |
-
2005
- 2005-06-01 KR KR1020050046891A patent/KR100670615B1/en not_active IP Right Cessation
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101239175B1 (en) * | 2009-08-28 | 2013-03-06 | 박헌경 | Method for manufacturing fodder with blc powder |
KR101872159B1 (en) * | 2017-06-29 | 2018-07-31 | 서정익 | Composition for the production of egg containing combated cancer and its Manufacturing method |
KR20190119312A (en) * | 2018-04-12 | 2019-10-22 | 재단법인 경기도경제과학진흥원 | Insecticidal and Miticidal Composition of Red Poultry Mite Using an Extract of Gleditsiae Fructus |
Also Published As
Publication number | Publication date |
---|---|
KR100670615B1 (en) | 2007-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Jimoh et al. | Comparison of the nutritive value, antioxidant and antibacterial activities of Sonchus asper and Sonchus oleraceus | |
CN102204629B (en) | Feed additive and preparation method thereof | |
Okwu et al. | Effects of hexane extract and phytochemical content of Xylopia aethiopica and Ocimum gratissimum on the uterus of guinea pig | |
Rani et al. | Prosopis cineraria (L.) Druce: A desert tree to brace livelihood in Rajasthan | |
KR102149215B1 (en) | Composition for bee feeding liquid to improve honey collecting ability and preparing method of thereof | |
Abd El-Hack et al. | Pharmacological, nutritional and antimicrobial uses of Moringa oleifera Lam. leaves in poultry nutrition: an updated knowledge | |
KR100670615B1 (en) | Manufacturing method of anticancer egg and anticancer egg | |
KR101031140B1 (en) | Pharmaceutical composition for preventing and treating cancer and health functional food containing thereof for preventing and improving cancer | |
US11304983B2 (en) | Medicated honey and method of preparation thereof | |
KR20090098024A (en) | The method of manufacturing of medicinal wine | |
Sahoo et al. | Evaluation of lactogenic activity of Triumfetta rhomboidea L. root: Validating its traditional usage. | |
KR100920713B1 (en) | A composition for the treatment or prevention of diarrhea | |
RU2544059C2 (en) | Selective honey and method of its production | |
KR20060125078A (en) | Manufacturing method of anticancer rice and anticancer rice | |
KR20060125075A (en) | Anticancer agent, food and manufacturing method of anticancer agent and food | |
US20040185124A1 (en) | Health food and antitumor agent | |
KR20120124659A (en) | A breeding method of protaetia breviitarsis, protaetia breviitarsis using the same, extracts from the same, a pharmaceutical composition for prevention or treatment of liver disease and health functional foods comprising the same as an effective component | |
KR20140041187A (en) | Anti-cancer composition containing erythronium japonicum extract | |
KR101371079B1 (en) | Manufacturing Method of Functional Fermentation Products using CHEJU Scoria and Functional Plants and Culturing Method | |
Olusola et al. | Assessment of dietary supplementation of thorn apple (Datura stramonium) seed on growth and reproductive performance of Clarias gariepinus broodstock | |
RU2375070C1 (en) | Method for making proanthocyanidines of scotch pine bark | |
CN105918697B (en) | Feed additive, preparation method thereof and application thereof in aquatic animal feed | |
KR20160143938A (en) | PREPARATION METHOD OF Artemisia annua EXTRACT AND COMPOSITIONS CONTAINING OF THE SAME | |
RU2792652C1 (en) | Functional food with tonic properties | |
KR100479683B1 (en) | Compound Forage made of Condonopis Lenciolata and Its Manufacturing Process |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20111121 Year of fee payment: 6 |
|
LAPS | Lapse due to unpaid annual fee |